Member Info for ihowells

Very impressive presentation and the range of cancers that the Parsotix technology can focus on is enlarging, with prostate and also lung being mentioned. FDA answer in H2 so let’s hope it’s the earlier part so we can kick on.

I think SEZZ may be correct but I may be proved wrong. There seems decent support at 6.2 and this goes back to Dec 2020. My average is 3.4 p and did pick some up at 2,5p although it was scared times when it hit 1.5p at the start of COVID. I think there may be people looking to pick up stock especially after the HZM tweet earlier.

I have a large position in HZM spread over various accounts. The bulk of which I intend to keep until production in hopefully late 2023 where I expect it to be in the 40/50p area. This is attainable as long as there is minimal dilution for the last piece of finance.
I still think there’s a fair chance that they get bought out as someone will want Vermellho for the battery grade nickel. My opinion of course.

Yes Bojo, looks like Archers buy in SAV has given it a push. I wanted to put some profits from ARC into ACP, but the way that’s dragging on I might have missed the boat.

HL are an absolute sh*t shower! You have my sympathy after them taking 5 months to transfer shares to IG as they weren’t allowing Bed and ISA’s.

Come on TERN let’s break through 30p!

Courtesy of Thoth2 from SAR bb,

https://www.nationalheraldindia.com/opinion/with-new-variants-likely-to-come-up-it-is-imperative-to-have-a-foolproof-covid-vaccination-strategyhttps://www.nationalheraldindia.com/opinion/with-new-variants-likely-to-come-up-it-is-imperative-to-have-a-foolproof-covid-vaccination-strategy

Millermick has gone in my green bin. Hopefully not to be seen or heard from again.

Let’s see how the market interprets this tomorrow. It is only a small discount at 116p though.

Xviolet if you think SAR is good for only 20p long term you are selling it short IMO. COVID might be a starter but there are more molecules for autoimmune and cancer not to lose track off.

My rule, “sit on your hands and believe in the company and or products”. Not for everyone I know. :-)

Celtic, well that’s 2 of us that lost money in Xcite Energy. I don’t have the heart to look back to see how much I lost. Will perhaps do when I cash in some SAR, not cashing in soon though!

Yes I agree, lots to be positive about. Hold for gold as they say, or in this case tin, lithium and tantalum.

Well a nice start to the week for SAR xViolet. Up 16% in first half hour.

On HZM here’s my opinion and DYOR of course.

I think…without evidence…it’s being forward sold by one of the II’s ahead of finance. The worrying thing if they are selling here does it mean that the last bit of finance will be done around 6.5/6.75p? If so that is disappointing for long term holders but also for the institutions that partook at 7.5p I guess.

There is going to be a nickel shortage for the EV market by 2025/26 is the forecast. Araguaia will be first on stream but that’s for the stainless steel market hopefully by 2024. HZM will, in my opinion and also of Jeremy Martin, the CEO be unable to run both. Therefore for Vermelho, the jewel in the crown as it can supply nickel for the EV market, it looks likely being a JV. There will be lots of companies looking at this asset but all eyes on the DFS to be completed soon. Lots to love but more money to be made when in production IMO.

Don’t worry Noloplus, I am in for the long haul. Never a dull moment when TB is in town but the quality of IQAI’s portfolio is in no doubt.

And what happens after Trevor forward sells? Hope I’m wrong….

Yes my green filter box is going into Overdrive. I guess GReesyspoon is giving us the pleasure of his company.

Riseup have you seen the interview clip with the CEO of Wilde Networks? Well worth a watch to see their plans and don’t forget TERN will still retain approx 60% after it’s listing.

Noloplus is your man for BRH as have never been invested. Think he has made good money out of the share and is good at reading TB’s “disturbed” mind. :-)

Hi Xv, the SAR board has some great posters with great medical and molecular knowledge like Toth. SAR have a range of molecules which will hopefully work in COVID, immunotherapy and cancer so no one trick pony. News is waiting on entry in Agile but other news can drop any time also. Nobody likes buying at the top but all loose shares are being hoovered up at mom.I am in for the long haul on this one as COVID news would be a bonus but not an exit for me, Cheers.